Rhythm Pharmaceuticals Inc <RYTM.O>: J.P. Morgan initiates coverage with overweight rating; price target $145
RYTM•Related News
Canadian National Railway Co <CNR.TO>: JP Morgan Raises Target Price to C$182 From C$175
CNI•
War? What war? Aluminium's Gulf disruption premium vanishes
XLB•
Southside Bancshares Inc <SBSI.N>: Piper Sandler cuts target price to $33 from $37
SBSI•
Ovintiv Inc <OVV.N>: RBC raises target price to $85 from $70
OVV•
Warner Bros Discovery Inc <WBD.O>: Seaport Research Partners cuts to neutral from buy
WBD•